Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steven A Porcelli

Showing results (21-30 of 186) with videos related to

Pageof 19
Sort By:
Clinical & Translational Immunology|May 20, 2016
Synthetic glycolipid activators of natural killer T cells as immunotherapeutic agentsLeandro J Carreño, Noemí A Saavedra-Ávila, Steven A Porcelli
Mbio|January 20, 2021
Sterilization by Adaptive Immunity of a Conditionally Persistent Mutant of Mycobacterium tuberculosisCatherine Vilchèze, Steven A Porcelli, John Chan, et al.
Journal of Immunological Methods|January 22, 2013
In vitro derivation of macrophage from guinea pig bone marrow with human M-CSFKarl O A Yu, Steven A Porcelli, Howard A Shuman
The Journal of Experimental Medicine|February 16, 2005
Mycobacterium tuberculosis controls host innate immune activation through cyclopropane modification of a glycolipid effector moleculeVivek Rao, Nagatoshi Fujiwara, Steven A Porcelli, et al.
Molecular Microbiology|July 2, 2004
Mycobacterial lipoarabinomannan and related lipoglycans: from biogenesis to modulation of the immune responseVolker Briken, Steven A Porcelli, Gurdyal S Besra, et al.
Msphere|August 4, 2021
Mycobacterium tuberculosis PE_PGRS20 and PE_PGRS47 Proteins Inhibit Autophagy by Interaction with Rab1AEmily J Strong, Tony W Ng, Steven A Porcelli, et al.
Frontiers in Immunology|July 26, 2021
Aspirin Actions in Treatment of NSAID-Exacerbated Respiratory DiseaseEsha Sehanobish, Mohammad Asad, Mali Barbi, et al.
Frontiers in Immunology|September 12, 2022
A century of BCG vaccination: Immune mechanisms, animal models, non-traditional routes and implications for COVID-19Shivani Singh, Noemi Alejandra Saavedra-Avila, Sangeeta Tiwari, et al.
Bioorganic & Medicinal Chemistry Letters|May 14, 2010
Synthesis and biological activity of alpha-L-fucosyl ceramides, analogues of the potent agonist, alpha-D-galactosyl ceramide KRN7000Natacha Veerapen, Faye Reddington, Gabriel Bricard, et al.
Methods in Molecular Biology (Clifton, N.J.)|June 30, 2018
Identification of Novel Mycobacterial Targets for Murine CD4<sup>+</sup> T-Cells by IFNγ ELISPOTAlison J Johnson, Steven C Kennedy, Tony W Ng, et al.
Pageof 19

Showing results (21-30 of 186) with videos related to

Sort By:
Pageof 19
Clinical & Translational Immunology|May 20, 2016
Synthetic glycolipid activators of natural killer T cells as immunotherapeutic agentsLeandro J Carreño, Noemí A Saavedra-Ávila, Steven A Porcelli
Mbio|January 20, 2021
Sterilization by Adaptive Immunity of a Conditionally Persistent Mutant of Mycobacterium tuberculosisCatherine Vilchèze, Steven A Porcelli, John Chan, et al.
Journal of Immunological Methods|January 22, 2013
In vitro derivation of macrophage from guinea pig bone marrow with human M-CSFKarl O A Yu, Steven A Porcelli, Howard A Shuman
The Journal of Experimental Medicine|February 16, 2005
Mycobacterium tuberculosis controls host innate immune activation through cyclopropane modification of a glycolipid effector moleculeVivek Rao, Nagatoshi Fujiwara, Steven A Porcelli, et al.
Molecular Microbiology|July 2, 2004
Mycobacterial lipoarabinomannan and related lipoglycans: from biogenesis to modulation of the immune responseVolker Briken, Steven A Porcelli, Gurdyal S Besra, et al.
Msphere|August 4, 2021
Mycobacterium tuberculosis PE_PGRS20 and PE_PGRS47 Proteins Inhibit Autophagy by Interaction with Rab1AEmily J Strong, Tony W Ng, Steven A Porcelli, et al.
Frontiers in Immunology|July 26, 2021
Aspirin Actions in Treatment of NSAID-Exacerbated Respiratory DiseaseEsha Sehanobish, Mohammad Asad, Mali Barbi, et al.
Frontiers in Immunology|September 12, 2022
A century of BCG vaccination: Immune mechanisms, animal models, non-traditional routes and implications for COVID-19Shivani Singh, Noemi Alejandra Saavedra-Avila, Sangeeta Tiwari, et al.
Bioorganic & Medicinal Chemistry Letters|May 14, 2010
Synthesis and biological activity of alpha-L-fucosyl ceramides, analogues of the potent agonist, alpha-D-galactosyl ceramide KRN7000Natacha Veerapen, Faye Reddington, Gabriel Bricard, et al.
Methods in Molecular Biology (Clifton, N.J.)|June 30, 2018
Identification of Novel Mycobacterial Targets for Murine CD4<sup>+</sup> T-Cells by IFNγ ELISPOTAlison J Johnson, Steven C Kennedy, Tony W Ng, et al.
Pageof 19